DK1001775T3 - Medikament indeholdende yohimbin og arginin beregnet til behandling af erektil dysfunktion - Google Patents

Medikament indeholdende yohimbin og arginin beregnet til behandling af erektil dysfunktion

Info

Publication number
DK1001775T3
DK1001775T3 DK98935102T DK98935102T DK1001775T3 DK 1001775 T3 DK1001775 T3 DK 1001775T3 DK 98935102 T DK98935102 T DK 98935102T DK 98935102 T DK98935102 T DK 98935102T DK 1001775 T3 DK1001775 T3 DK 1001775T3
Authority
DK
Denmark
Prior art keywords
arginine
erectile dysfunction
intended
treat erectile
medication containing
Prior art date
Application number
DK98935102T
Other languages
Danish (da)
English (en)
Inventor
Philippe Gorny
Original Assignee
Real 2000 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Real 2000 Ltd filed Critical Real 2000 Ltd
Application granted granted Critical
Publication of DK1001775T3 publication Critical patent/DK1001775T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98935102T 1997-07-04 1998-07-06 Medikament indeholdende yohimbin og arginin beregnet til behandling af erektil dysfunktion DK1001775T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9708504A FR2765483B1 (fr) 1997-07-04 1997-07-04 Medicament destine a traiter les dysfonctions erectiles
PCT/FR1998/001438 WO1999001132A1 (fr) 1997-07-04 1998-07-06 Medicament, contenant de la yohimbine et de l'arginine, destine a traiter les dysfonctions erectiles

Publications (1)

Publication Number Publication Date
DK1001775T3 true DK1001775T3 (da) 2002-04-29

Family

ID=9508874

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98935102T DK1001775T3 (da) 1997-07-04 1998-07-06 Medikament indeholdende yohimbin og arginin beregnet til behandling af erektil dysfunktion

Country Status (17)

Country Link
US (1) US20020155136A1 (zh)
EP (1) EP1001775B1 (zh)
JP (1) JP2002511875A (zh)
KR (1) KR20010021505A (zh)
CN (1) CN1261798A (zh)
AT (1) ATE212841T1 (zh)
AU (1) AU743825B2 (zh)
BR (1) BR9810981A (zh)
CA (1) CA2295916A1 (zh)
DE (1) DE69803773T2 (zh)
DK (1) DK1001775T3 (zh)
ES (1) ES2172171T3 (zh)
FR (1) FR2765483B1 (zh)
ID (1) ID24184A (zh)
IL (1) IL133443A0 (zh)
PT (1) PT1001775E (zh)
WO (1) WO1999001132A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
DE19831263A1 (de) 1998-07-11 2000-01-13 Lohmann Therapie Syst Lts Darreichungsform
DE60026146T2 (de) * 1999-09-03 2006-08-17 Apbi Holdings, Llc Verwendung von Dapoxetin, A selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Disfunktion
SI1086695T1 (en) * 1999-09-21 2005-06-30 Enzo Leone Antiviral compositions comprising yohimbine as active principle
AU2001282373A1 (en) * 2000-05-26 2001-12-03 Horphag Research Limited Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion
KR20010016165A (ko) * 2000-11-16 2001-03-05 정순학 성기능 장애 치료를 위한 피부에 적용하는 제제
ITMI20020990A1 (it) * 2002-05-10 2003-11-10 Indena Spa Formulazioni utili nel trattamento dell'impotenza maschile e femminile
ITMI20020994A1 (it) * 2002-05-10 2003-11-10 Indena Spa Formulazioni utili nel trattamento dell'impotenza maschile e femminile
HUP0401422A2 (en) 2004-07-15 2006-04-28 G Laszlo Meszaros Use of l-arginine as vasoaktive ingredient absorbing through skin for external application
DE102005053241A1 (de) * 2005-11-08 2007-05-16 Schwabe Willmar Gmbh & Co Extrakte aus der Rinde von Corynanthe-Arten und deren Verwendung sowie diese Extrakte enthaltende Arzneimittel, diätetische Lebensmittel und pharmazeutische Zubereitungen
CN111840508A (zh) * 2020-07-17 2020-10-30 北京清大赛尔生物科技有限公司 一种预防及治疗男性性功能障碍的外用制剂及其应用
CN113116905A (zh) * 2021-04-20 2021-07-16 北京天玺宝科技有限公司 一种增强男性性功能并持续改善性功能障碍的组合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response

Also Published As

Publication number Publication date
EP1001775B1 (fr) 2002-02-06
ATE212841T1 (de) 2002-02-15
CN1261798A (zh) 2000-08-02
FR2765483B1 (fr) 2000-02-04
KR20010021505A (ko) 2001-03-15
EP1001775A1 (fr) 2000-05-24
ID24184A (id) 2000-07-13
DE69803773T2 (de) 2002-08-29
AU8446798A (en) 1999-01-25
FR2765483A1 (fr) 1999-01-08
JP2002511875A (ja) 2002-04-16
ES2172171T3 (es) 2002-09-16
PT1001775E (pt) 2002-07-31
IL133443A0 (en) 2001-04-30
WO1999001132A1 (fr) 1999-01-14
CA2295916A1 (en) 1999-01-14
US20020155136A1 (en) 2002-10-24
AU743825B2 (en) 2002-02-07
DE69803773D1 (de) 2002-03-21
BR9810981A (pt) 2000-08-15

Similar Documents

Publication Publication Date Title
DK1001775T3 (da) Medikament indeholdende yohimbin og arginin beregnet til behandling af erektil dysfunktion
TR200102648T2 (tr) Büyümeyi destekleyen bileşimler
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
ATE242633T1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
ATE264692T1 (de) Verwendung von no synthase hemmern und fängern von reaktiven sauerstoffsformen zur behandlung von ischämie
DE60321929D1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
DK0776202T3 (da) Liposomalt indkapslet taxol, dets fremstilling af dets anvendelse
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
SE9701161D0 (sv) New use I
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
EP1037918A4 (en) METHOD AND COMPOSITIONS FOR INCREASING THE EFFICIENCY OF VACCINALS USING CHEMOKINES
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE239488T1 (de) Verwendung von wirkstoffkombinationen aus antibiotika und terpenhaltigen pflanzenextrakten in der tiermedizin
DK139685A (da) Liposomer med inhalative allergener til behandling af allergier, fremgangsmaade til deres fremstilling og laegemidler indeholdende disseliposomer
IL156144A0 (en) Novel therapeutic use of a thienylcyclohexylamine derivative
ES2051788T3 (es) Un producto farmaceutico.
HK1058305A1 (en) Combinations of dalfopristine/quinupristine with cefpirome
UA36485A (uk) Спосіб лікування генералізованого пародонтиту
MX9706411A (es) Uso de aerogeles en agricultura.
ATE314073T1 (de) Kombination von aktiva mit alfuzosin und apomorphin